ORM1 and breast carcinoma: Moreover, compared with the normal breast cell line HBL-100, the expression of ORM1 was increased in the MDA-MB-231 breast cancer cell line and the epirubicin-resistant MDA-MB-231/EPI cell line (Figure 1(d)).